Unusual Case of Simultaneous Presentation of Plasma Cell Myeloma, Chronic Myelogenous Leukemia, and a Jak2 Positive Myeloproliferative Disorder

Background. Multiple articles discuss the rare incidence and potential causes of second hematologic disorders arising after treatment of Chronic Myelogenous Leukemia (CML), leading to the theory of imatinib, the current treatment regimen for CML, as a possible trigger for the development of secondar...

Descripción completa

Detalles Bibliográficos
Autores principales: Maerki, J., Katava, G., Siegel, D., Silberberg, J., Bhattacharyya, P. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4214051/
https://www.ncbi.nlm.nih.gov/pubmed/25386371
http://dx.doi.org/10.1155/2014/738428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4214051/
https://www.ncbi.nlm.nih.gov/pubmed/25386371
http://dx.doi.org/10.1155/2014/738428

Ejemplares similares